18F-FLUDEOXYGLUCOSE (18F-FDG) 7400 MBq

18F-Fludeoxyglucose (18F-FDG) 7400 MBq is a radiopharmaceutical solution used in diagnostic imaging. This intravenous solution is manufactured by Isologic Innovative Radiopharmaceuticals Ltd. in Canada.

18F-Fludeoxyglucose (18F-FDG) is primarily used in positron emission tomography (PET) scans to help visualize metabolic processes in the body. It is often utilized in the assessment of various conditions, including but not limited to, cancer, heart disease, and neurological disorders. The solution is administered intravenously and helps in identifying areas of high metabolic activity.

The effects of 18F-Fludeoxyglucose (18F-FDG) are primarily observed through imaging techniques. It is designed to be taken up by cells with high metabolic rates, which can then be detected using PET scans. This helps in providing detailed images that can aid in the evaluation of various medical conditions.

Handling 18F-Fludeoxyglucose (18F-FDG) requires strict adherence to safety protocols due to its radioactive nature. It should be used under the supervision of qualified healthcare professionals. Proper shielding and disposal methods must be followed to ensure safety.

18F-Fludeoxyglucose (18F-FDG) may interact with certain medications and substances. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, before undergoing a PET scan. Alcohol and certain foods may also affect the accuracy of the scan results.